Article
Targeting HDACs in Pancreatic Neuroendocrine Tumor Models
6 Jun 2021
Abstract excerpt
Compared to pancreatic adenocarcinoma (PDAC), pancreatic neuroendocrine tumors (PanNET) represent a rare and heterogeneous tumor entity. In addition to surgical resection, several therapeutic approaches, including biotherapy, targeted therapy or chemotherapy are applicable. However, primary or secondary resistance to current therapies is still challenging. Recent genome-wide sequencing efforts in PanNET...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
